Pre-approved by WHO, Qdenga dengue vaccine shows 50 pc efficacy, lasting effects: Study, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

The authors also found that among those receiving a single vaccine dose, more than 70 per cent of adults and over 90 per cent of children and adolescents developed antibodies against the viral infection., The authors also found that among those receiving a single vaccine dose, more than 70 per cent of adults and over 90 per cent of children and adolescents developed antibodies against the viral infection., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *